[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pulmonx Corp (LUNG)

Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 87,614
  • Shares Outstanding, K 42,948
  • Annual Sales, $ 90,500 K
  • Annual Income, $ -54,000 K
  • EBIT $ -37 M
  • EBITDA $ -53 M
  • 60-Month Beta 0.28
  • Price/Sales 0.97
  • Price/Cash Flow N/A
  • Price/Book 2.21

Options Overview Details

View History
  • Implied Volatility 140.74% (-7.07%)
  • Historical Volatility 122.30%
  • IV Percentile 10%
  • IV Rank 5.95%
  • IV High 651.31% on 03/20/26
  • IV Low 108.46% on 03/06/26
  • Expected Move (DTE 12) 0.30 (14.58%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 18
  • Volume Avg (30-Day) 367
  • Put/Call OI Ratio 12.91
  • Today's Open Interest 13,105
  • Open Int (30-Day) 10,005
  • Expected Range 1.74 to 2.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.26
  • Number of Estimates 2
  • High Estimate $-0.26
  • Low Estimate $-0.26
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.17 +74.36%
on 07/24/26
2.21 -7.69%
on 08/06/26
+0.51 (+33.33%)
since 07/07/26
3-Month
1.17 +74.36%
on 07/24/26
2.21 -7.69%
on 08/06/26
+0.77 (+60.63%)
since 05/07/26
52-Week
1.13 +80.53%
on 03/30/26
2.89 -29.41%
on 10/28/25
+0.42 (+25.93%)
since 08/07/25

Most Recent Stories

More News
Pulmonx Reports Second Quarter 2026 Financial Results

REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (-0.49%)
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference

REDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...

LUNG : 2.04 (-0.49%)
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026

REDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...

LUNG : 2.04 (-0.49%)
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (-0.49%)
Pulmonx Reports First Quarter 2026 Financial Results

REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (-0.49%)
Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

REDWOOD CITY, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...

LUNG : 2.04 (-0.49%)
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...

LUNG : 2.04 (-0.49%)
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (-0.49%)
Pulmonx Announces Closing of up to $60 Million Credit Facility

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the “Company” or “Pulmonx”), a global leader in minimally invasive treatments for lung disease, today...

LUNG : 2.04 (-0.49%)
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...

LUNG : 2.04 (-0.49%)

Business Summary

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

See More

Key Turning Points

3rd Resistance Point 2.18
2nd Resistance Point 2.14
1st Resistance Point 2.09
Last Price 2.04
1st Support Level 2.00
2nd Support Level 1.96
3rd Support Level 1.91

See More

52-Week High 2.89
Fibonacci 61.8% 2.22
Last Price 2.04
Fibonacci 50% 2.01
Fibonacci 38.2% 1.80
52-Week Low 1.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.